The Truth About Recovery: Why Withdrawal Takes Years
In a Nutshell
Withdrawal symptoms can last years and are routinely misread as relapse or new illness, especially when no pre-medication baseline exists. New or random sensitivities, physical symptoms, and diagnostic escalation while on meds are key red flags that the drugs—not the original condition—are driving the problem. Accurate identification requires slow hyperbolic tapering and long observation rather than quick reinstatement of lifelong treatment.
These notes were generated by AI and may contain inaccuracies.
If a symptom has never been experienced before, it can likely be assumed to be withdrawal. When symptoms mimic struggles that existed before medication, time becomes the best indicator—not just a few weeks or months, but potentially years. For those medicated since childhood, establishing any sense of baseline can take significant time because no pre-medication baseline was ever experienced.
It is difficult to quickly determine what represents the true self versus medication effects versus withdrawal effects. It may never be fully possible to separate these elements completely.
A unique moment exists to build bridges between former patients who have become leading experts on safe tapering and doctors leading hyperbolic tapering approaches, such as Mark Horowitz and Josef Witt-Doerring. These doctors have acknowledged learning much from patients who figured out tapering methods first. The goal is collaboration rather than confrontation, with deep prescribing positioned as an invitation to psychiatry, not a threat.
All parties share the goal of helping people feel better in their lives. Deep prescribing should not be an us-versus-them issue. The Maudsley Deprescribing Guidelines describe hyperbolic tapering as the clearest approach for creating the safest possible tapering protocols. These protocols should be made available for clinician training and for patients and families. Working together with psychiatry, guild organizations, and establishment institutions is presented as a win-win approach focused on helping rather than threatening.
Many doctors feel frustrated when patients worsen despite efforts to help, often by adding stabilizing medications as taught in medical school. For a percentage of the population, each additional medication worsens symptoms. Differentiating protracted withdrawal from other issues remains challenging. New symptoms provide clearer indicators: if someone entered treatment with anxiety and depression but develops extreme agitation, insomnia, hallucinations, or new sensitivities after stopping medication, these point toward withdrawal rather than relapse.
Random new sensitivities represent a significant withdrawal sign. Examples include developing food sensitivities that did not previously exist or becoming unable to tolerate light that was previously manageable. These represent changes that cannot be attributed to a pre-existing condition.
A widespread distortion exists among doctors, therapists, patients, and families: the belief that how someone feels when stopping medication represents their untreated baseline. This is not true. Decisions should not be made based on difficulty experienced off medication without first considering reinstatement followed by slower tapering. New diagnoses should be avoided, and conclusions that someone needs lifelong medication should not be drawn during withdrawal periods.
Two major distorting narratives contribute to high long-term medication use: withdrawal mistaken for relapse, and long-term adverse effects or adverse effects mistaken for worsening of the original condition. An estimated 65 million Americans are currently on these medications, most long-term, partly due to misinterpretation of what is occurring.
When withdrawal is not recognized, everything observed gets diagnosed as relapse of the original illness. Once this misattribution stops, clinical observations are expected to change significantly.
If someone enters treatment with major depressive disorder and receives a bipolar diagnosis four years later, the medication trajectory moves in the wrong direction because the person should be improving rather than worsening.
Physical symptoms experienced while on multiple medications were initially attributed to arthritis or autoimmune disorders. After entering withdrawal, it became clear that some physical symptoms were actually caused by the antidepressant rather than the autoimmune condition. Specific examples include fibromyalgia-like nerve pain and severe restless legs syndrome.
Restless legs syndrome began badly around age 18 and worsened progressively. Medication started at age 12, meaning approximately six years on medication before the symptom intensified. The symptom was severe enough to cause hitting legs on a bus while crying during university in Montreal. After withdrawal began, other pain symptoms worsened, but the restless legs component resolved relatively quickly, confirming it had been a medication side effect rather than part of the autoimmune disorder.
Keep Mikhaila Peterson in your library
Save the videos and channels worth coming back to, and find them again in one place.
